Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Abirami Shankar"'
Autor:
Yamuna Devi Bakthavatchalam, Abirami Shankar, Dhiviya Prabaa Muthuirulandi Sethuvel, Kalaiarasi Asokan, Kalaiarasi Kanthan, Balaji Veeraraghavan
Publikováno v:
Future Science OA, Vol 6, Iss 4 (2020)
Aim: To evaluate the antibacterial activity of fosfomycin–meropenem and fosfomycin–colistin combinations against carbapenem-resistant Klebsiella pneumoniae (CR-Kp). Methods: A total of 50 CR-Kp isolates recovered from blood cultures were included
Externí odkaz:
https://doaj.org/article/36a7e5de1b0e4e6190f753b8894e0ca7
Autor:
Saranya Vijayakumar, Rayapadi G. Swetha, Yamuna Devi Bakthavatchalam, Karthick Vasudevan, Baby Abirami Shankar, Agilandeeswari Kirubananthan, Kamini Walia, Sudha Ramaiah, Indranil Biswas, Balaji Veeraraghavan, Anand Anbarasu
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 2 (2024)
ABSTRACTColistin resistance in Acinetobacter baumannii is mediated by multiple mechanisms. Recently, mutations within pmrABC two-component system and overexpression of eptA gene due to upstream insertion of ISAba1 have been shown to play a major role
Externí odkaz:
https://doaj.org/article/62bbe26bb6b64c6fa855971e05f79c82
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Suriya Chandran, Yuvasri Manokaran, Saranya Vijayakumar, Baby Abirami Shankar, Yamuna Devi Bakthavatchalam, Hariharan Triplicane Dwarakanathan, Binesh Lal Yesudason, Balaji Veeraraghavan
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 42:645-651
Autor:
Yamuna Devi Bakthavatchalam, Divyaa Elangovan, Subha Vajjiravelu Jaganathan, Nivedhana Subburaju, Abirami Shankar, Yuvasri Manokaran, Sudarsana J., Rema Devi, Sujata Baveja, Sheela Devi, Jayakumar S., Sanjay Bhattacharya, Rudresh S. M., Bineshlal Yesudhason, Vignesh Shetty, Ankur Mutreja, Abi Manesh, George M. Varghese, Charis A. Marwick, Benjamin J. Parcell, Ian H. Gilbert, Balaji Veeraraghavan
Publikováno v:
Microbiology Spectrum. 11
The study revealed the differential ability of cefepime/taniborbactam and cefepime/zidebactam in tackling carbapenemase-producing Indian clinical isolates that also harbored additional mechanisms of resistance. NDM-expressing E. coli with 4-amino-aci
Autor:
Yamuna Devi Bakthavatchalam, Abirami Shankar, Yuvasri Manokaran, Kamini Walia, Balaji Veeraraghavan
Publikováno v:
JAC-Antimicrobial Resistance. 5
NDM-expressing Escherichia coli infections are challenging to treat, due to limited treatment options. E. coli with four-amino acid inserts (YRIN/YRIK) are also common in India and it has been reported to reduce the susceptibility to aztreonam/avibac
Publikováno v:
Journal of Nursing Practices and Research. 1:27-33
Background: Breastfeeding provides the finest nutrients for nourished babies. It is the ideal diet for a child's growth and development. Despite the well-publicized importance of EBF in developing nations, many communities continue to have the highes
Autor:
Balaji Veeraraghavan, Aniket Naha, Sudha Ramaiah, Baby Abirami Shankar, Saranya Vijayakumar, Anand Anbarasu, Binesh Lal, Suriya Chandran
Publikováno v:
Journal of Cellular Biochemistry. 122:1946-1957
Acinetobacter baumannii is an emerging nosocomial strain expressing extensive drug resistance (XDR). Whole-genome sequencing and molecular characterisation analysis revealed the presence of carbapenemase in 92.86% of studied Indian isolates having bl
Autor:
Yamuna Devi Bakthavatchalam, Soumya Basu, Abirami Shankar, Sudha Ramaiah, Anand Anbarasu, Balaji Veeraraghavan
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 105:115878
The present study reported a rare gentamicin-susceptible β-lactamase (PenA, OXA-57) expressing clinical Burkholderia pseudomallei isolate VB29710 from India. Whole-genome sequencing and structural analyses revealed the insertion of R962 and L963 int
Autor:
Biju George, Balaji Veeraraghavan, Yamuna Devi Bakthavatchalam, Pritish John Korula, Agila Kumari Pragasam, Alice Joan Mathuram, Baby Abirami Shankar, Binila Chacko, Shalini Anandan
Publikováno v:
Indian Journal of Medical Microbiology, Vol 37, Iss 1, Pp 34-41 (2019)
Introduction: Carbapenem resistance (CR) in Klebsiella pneumoniae is mainly mediated by bla NDM and bla OXA-48 carbapenemases. Newer Food and Drug Administration-approved antimicrobial ceftazidime/avibactam (C/A) has a potent activity against bla OXA